CD276 and colorectal carcinoma: Meng et al. showed that the synthesized miR-34a analog NS-MX3 simultaneously decreased the expression of B7-H3 and PD-L1 and demonstrated superior antitumor activity in CRC models in vitro and in vivo [199].